Understand how combining proprietary and real-world datasets with tokenization enables accurate protocol matching while ...
In today’s ACT Brief, we explore how real-world data can improve protocol design and feasibility, highlight new findings from ...
Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and ...
4don MSN
Pulse Biosciences targets Q1 completion of PRECISE-BTN study enrollment as clinical adoption grows
Q3 2025 Management View CEO Paul LaViolette highlighted significant momentum across Pulse Biosciences’ three market development programs, emphasizing early adoption and progress in clinical trials.
The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major ...
The Clinical Research Unit (CRU) is committed to providing investigators and their teams a research environment and broad range of services guided by good clinical practice. This contributes to the ...
Tenaya Therapeutics said on Friday the U. Food and Drug Administration has placed a clinical hold on its trial of an ...
Enspectra Health today announced the publication of pivotal clinical trial results in JAMA Dermatology, demonstrating that its handheld cross-modal imaging system enables physicians to accurately iden ...
The Phase IIb study has been strategically designed to meet regulatory expectations for pivotal clinical evidence. Its larger sample size, rigorous randomization, and multi-site structure enhance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback